| Primary |
| Hypertension |
34.8% |
| Osteoporosis |
8.7% |
| Type 2 Diabetes Mellitus |
7.6% |
| Diabetes Mellitus |
5.4% |
| Essential Hypertension |
5.4% |
| Pain |
5.4% |
| Sciatica |
4.3% |
| Arrhythmia |
3.3% |
| Angina Pectoris |
2.2% |
| Anxiety |
2.2% |
| Asthma |
2.2% |
| Depression |
2.2% |
| Glucose Tolerance Impaired |
2.2% |
| Lung Infection |
2.2% |
| Proctocolitis |
2.2% |
| Prothrombin Level Decreased |
2.2% |
| Pyrexia |
2.2% |
| Renal Transplant |
2.2% |
| Sleep Disorder |
2.2% |
| Angiopathy |
1.1% |
|
| Renal Failure Acute |
9.4% |
| Anxiety |
6.3% |
| Breast Cancer |
6.3% |
| Death |
6.3% |
| Diabetes Mellitus |
6.3% |
| Humerus Fracture |
6.3% |
| Hypertension |
6.3% |
| Intervertebral Disc Protrusion |
6.3% |
| Lactic Acidosis |
6.3% |
| Pneumonia |
6.3% |
| Vomiting |
6.3% |
| Abasia |
3.1% |
| Balance Disorder |
3.1% |
| Basal Cell Carcinoma |
3.1% |
| Blood Pressure Fluctuation |
3.1% |
| Cataract |
3.1% |
| Colitis Microscopic |
3.1% |
| Constipation |
3.1% |
| Coronary Artery Occlusion |
3.1% |
| Drug Administration Error |
3.1% |
|
| Secondary |
| Product Used For Unknown Indication |
52.4% |
| Hypertension |
12.0% |
| Type 2 Diabetes Mellitus |
5.8% |
| Helicobacter Infection |
4.1% |
| Thrombosis |
4.1% |
| Dementia Alzheimer's Type |
2.4% |
| Depression |
2.4% |
| Drug Use For Unknown Indication |
2.1% |
| Urinary Tract Infection |
2.1% |
| Anxiety |
1.7% |
| Coronary Artery Disease |
1.7% |
| Antibiotic Therapy |
1.4% |
| Bronchopulmonary Aspergillosis |
1.4% |
| Essential Hypertension |
1.4% |
| Diabetes Mellitus |
1.0% |
| Gastritis |
1.0% |
| Pyrexia |
1.0% |
| Arrhythmia |
0.7% |
| Arthralgia |
0.7% |
| Dyslipidaemia |
0.7% |
|
| Renal Failure Acute |
20.0% |
| Renal Failure |
12.5% |
| Completed Suicide |
5.0% |
| Diarrhoea |
5.0% |
| Drug Ineffective |
5.0% |
| Dysgeusia |
5.0% |
| Gastrointestinal Ulcer |
5.0% |
| Hyponatraemic Encephalopathy |
5.0% |
| Shock Haemorrhagic |
5.0% |
| Sinus Bradycardia |
5.0% |
| Thrombosis |
5.0% |
| Asthenia |
2.5% |
| Blood Alkaline Phosphatase Increased |
2.5% |
| Blood Potassium Increased |
2.5% |
| Cardiogenic Shock |
2.5% |
| Colitis Microscopic |
2.5% |
| Coronary Artery Stenosis |
2.5% |
| Creatinine Renal Clearance Decreased |
2.5% |
| Dehydration |
2.5% |
| Dialysis |
2.5% |
|
| Concomitant |
| Hypertension |
25.8% |
| Product Used For Unknown Indication |
10.1% |
| Prophylaxis |
8.1% |
| Rheumatoid Arthritis |
7.4% |
| Nausea |
6.4% |
| Non-hodgkin's Lymphoma |
5.4% |
| Hiv Infection |
5.0% |
| Pain |
3.4% |
| Prostate Cancer Metastatic |
3.0% |
| Renal Cell Carcinoma |
2.7% |
| Type 2 Diabetes Mellitus |
2.7% |
| Arthralgia |
2.3% |
| Diabetes Mellitus |
2.3% |
| Ill-defined Disorder |
2.3% |
| Prostate Cancer |
2.3% |
| Psoriasis |
2.3% |
| Vitamin Supplementation |
2.3% |
| Depression |
2.0% |
| Hepatitis C |
2.0% |
| Myocardial Ischaemia |
2.0% |
|
| Hypoxia |
10.5% |
| Arrhythmia |
7.0% |
| Rectal Haemorrhage |
7.0% |
| Ulcerative Keratitis |
7.0% |
| Abdominal Pain |
5.3% |
| Anaemia |
5.3% |
| Hungry Bone Syndrome |
5.3% |
| Pyrexia |
5.3% |
| Sepsis |
5.3% |
| Upper Gastrointestinal Haemorrhage |
5.3% |
| Vulval Cellulitis |
5.3% |
| Arthritis |
3.5% |
| Asthma |
3.5% |
| Condition Aggravated |
3.5% |
| Drug Hypersensitivity |
3.5% |
| Dyspnoea |
3.5% |
| Haemorrhage |
3.5% |
| Hypocalcaemia |
3.5% |
| Hyponatraemia |
3.5% |
| Insomnia |
3.5% |
|
| Interacting |
| Coronary Artery Disease |
51.3% |
| Hypertension |
20.5% |
| Hyperlipidaemia |
12.8% |
| Blood Pressure |
5.1% |
| Convulsion |
5.1% |
| Depression |
2.6% |
| Gastritis |
2.6% |
|
| Drug Interaction |
33.3% |
| Syncope |
22.2% |
| Drug Hypersensitivity |
11.1% |
| Heart Rate Decreased |
11.1% |
| Hyponatraemic Encephalopathy |
11.1% |
| Skin Plaque |
11.1% |
|
